| Financial Year |
March 31 2023 |
| Monetary Funds |
374,513,788.88 |
| Held-for-trading Financial Assets |
813,000,000.00 |
| Notes Receivable |
222,205,013.31 |
| Accounts Receivable |
492,610,748.26 |
| Advances to Suppliers |
107,488,913.08 |
| Other Receivables |
17,446,868.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
584,221,880.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,024,449.37 |
| Total Current Assets |
2,713,845,364.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
620,188,259.91 |
| Under-construction Projects |
94,490,307.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,591,410.62 |
| R&D expenses |
-- |
| Goodwill |
99,861,880.49 |
| Long-Term Deferred and Prepaid Expenses |
1,687,128.50 |
| Deferred Income Tax Assets |
5,796,435.55 |
| Other Non-Current Assets |
6,681,142.50 |
| Sub-Total of Non-Current Assets |
974,296,564.98 |
| Total Assets |
3,688,141,929.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
75,510,677.82 |
| Accounts Payable |
238,890,461.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,771,236.67 |
| Taxes Payable |
18,434,435.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,704,351.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,354,177.74 |
| Other Current Liabilities |
37,077,632.05 |
| Sub-Total of Current Liabilities |
496,462,291.30 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
29,739,629.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,691,679.95 |
| Total Liabilities |
530,153,971.25 |
| Paid-In Capital(Or Share Stock) |
1,126,430,898.00 |
| Capital Surplus |
1,810,567,026.62 |
| Surplus Reserve |
14,642,440.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
197,966,467.06 |
| Minority Stockholder's Interest |
3,148,859.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,154,839,098.79 |
| Owner's Equity（Stockholder's Equity） |
3,157,987,958.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,688,141,929.94 |
